Publication details

Ibrutinib blocks CD40 signalling in malignant B cells by reducing TRAF4 levels.

Authors

MRÁZ Marek

Year of publication 2021
Type Conference abstract
MU Faculty or unit

Central European Institute of Technology

Citation

You are running an old browser version. We recommend updating your browser to its latest version.

More info